Veeva Vault CDMS Selected for Vivozon’s VVZ-149 Studies

Veeva Vault CDMS to manage clinical data for phase 2 and phase 3
post-operative pain trials

PLEASANTON, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CDMS?src=hash" target="_blank"gt;#CDMSlt;/agt;–Veeva
Systems (NYSE:VEEV) today announced that Vivozon, an innovative
pharmaceutical company developing small molecule treatments for patients
with central nervous system conditions, has selected Veeva
Vault CDMS to provide electronic data capture (EDC), coding, and
data cleaning for their upcoming studies of VVZ-149 to treat
post-operative pain.

Vivozon is focused on developing a new mechanism-based non-narcotic and
non-NSAID analgesic for patients suffering from operations, neuropathic
pain, cancer pain, and more. The studies will be multicenter,
randomized, double-blind, parallel group, placebo-controlled trials to
evaluate the efficacy and safety of VVZ-149 injections for the treatment
of post-operative pain following bunionectomy (phase 2) and
abdominoplasty (phase 3).

Veeva is proud to support innovative companies like Vivozon with Veeva
Vault CDMS, a unified data management solution for today’s clinical
trials. For more information on Vault CDMS, visit veeva.com/CDMS.

About Vivozon

Vivozon, Inc. is specialized in the discovery, development and
commercialization of small molecule drugs for the treatment of patients
with unmet CNS medical needs by applying an innovative approach to
rapidly identify lead compounds using its unique ex vivo/phenotypic
screening technology. The company is focused on the development of a
safe non-opioid-next-generation pain killer for patients suffering from
operations, neuropathic pain, cancer pain, and more. For more
information, visit www.vivozon.com.

About Veeva Systems

Veeva Systems Inc. is the leader in cloud-based software for the global
life sciences industry. Committed to innovation, product excellence, and
customer success, Veeva serves more than 700 customers, ranging from the
world’s largest pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices throughout
North America, Europe, Asia, and Latin America. For more information,
visit veeva.com.

Contacts

Roger Villareal
Veeva Systems
925-264-8885
[email protected]

Lisa Barbadora
Veeva Systems
610-420-3413
[email protected]